VIRAX HOLDINGS LIMITED (VHL)

VIRAX HOLDINGS LIMITED

ASX code: VHL
Listing Date: Fri, 19 Dec 1986
Website: http://www.virax.com.au/
Industry: Pharmaceuticals, Biotechnology & Life Sciences

Principal Activities:
Bio-pharmaceutical research and development investment.

Address:
89 High Street, Suite 220
KEW
VIC    3101

Phone: (03) 9854 6230
Fax: (03) 9853 5134

Executives & Directors

Mr Michael Humphris, Chairman, Non Exec. Director
Dr Larry Ward, CEO
Mr Ian Pyman, Non Exec. Director
Dr Albert King, Non Exec. Director
Mr John Morrison, CFO

Please contact the ASX to change these details

Company Podcasts

Subscribe to current and future audio events for this company by clicking on the podcast icon:

Subscribe to VIRAX HOLDINGS LIMITED Podcasts

Company ASX Announcements

Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.

 

View this company's details on the Australian Securities Exchange website

VIRAX HOLDINGS LIMITED (VHL) Events

Company (Stock Code) Date/Time Event Timezone:
Icon_timezone Australia/NSW
Dr David Beames Mon, 20 Nov 2006
11:00AM
VHL - Commencement of Phase II US trials - Dr David Beames, CEO Listen to this event
Add VIRAX HOLDINGS LIMITED to your alerts More Pharmaceuticals, Biotechnology & Life Sciences events Podcast of events for VIRAX HOLDINGS LIMITED
Wed, 26 Nov 2008
02:30PM
02:30PM Australia/Victoria
Annual General Meeting
Quest Beaumont Kew, 7 Studley Park Rd, Kew, VIC
Fri, 29 Aug 2008 Full Year Results
Thu, 28 Feb 2008 Interim Results
Tue, 27 Nov 2007
11:00AM
Annual General Meeting
Quest Beaumont Kew, 7 Studley Park Rd Kew VIC 3101
Thu, 30 Aug 2007 Full Year Results
Wed, 28 Feb 2007 Interim Results
Thu, 17 Aug 2006 Full Year Results
Thu, 16 Mar 2006 Interim Results
Mon, 21 Nov 2005
10:48AM
10:48AM Australia/Victoria
Annual General Meeting
Stamford Plaza Hotel, Balmoral Room, 111 Lt Collins Street, Melbourne VIC
 

VIRAX HOLDINGS LIMITED (VHL)

VIR201 South African Trial First patient Vaccinated Thu, 11 Dec 2008
Transgene Trial Results Tue, 3 Jun 2008
Form 603 and 605 from ANZ Mon, 12 May 2008
Convertible Notes and Quarterly Report to Trust and ASIC Wed, 30 Apr 2008
Shareholding update and Convertible Note Placement Tue, 29 Apr 2008
ANZ: Opes Prime Disclosure Thu, 17 Apr 2008
ANZ: Opes Prime Disclosure Wed, 16 Apr 2008
ANZ: Opes Prime Disclosure Tue, 15 Apr 2008
ANZ: Opes Prime Disclosure Mon, 14 Apr 2008
ANZ: Opes Prime Disclosure Fri, 11 Apr 2008

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.

Register for Boardroom Radio Alerts

Receive email alerts when companies
you are interested in broadcast events.

Already registered?
Manage your alerts here